Ysios Capital joins Neurona 120MUSD financing

by Ysios Capital

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced the successful completion of ...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

GP Bullhound Fund VI leads €23 million...

by GP Bullhound

Established in 2015, the Valencia-based HR software company, Sesame, h...

Photos Stream